Peapack-Gladstone Financial Corp’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$67.9M Sell
564,709
-3,266
-0.6% -$377K 0.87% 29
2025
Q4
$59.8M Buy
567,975
+2,094
+0.4% +$197K 0.75% 32
2025
Q3
$47.5M Sell
565,881
-32,701
-5% -$2.69M 0.62% 41
2025
Q2
$47.4M Sell
598,582
-25,432
-4% -$2.02M 0.67% 35
2025
Q1
$56M Sell
624,014
-74,951
-11% -$7M 0.83% 31
2024
Q4
$69.5M Sell
698,965
-3,781
-0.5% -$390K 1.01% 20
2024
Q3
$79.8M Sell
702,746
-2,094
-0.3% -$249K 1.15% 14
2024
Q2
$87.3M Sell
704,840
-6,507
-0.9% -$838K 1.34% 11
2024
Q1
$93.9M Buy
711,347
+14,139
+2% +$1.74M 1.47% 9
2023
Q4
$76M Sell
697,208
-9,110
-1% -$946K 1.28% 11
2023
Q3
$72.7M Sell
706,318
-1,052
-0.1% -$113K 1.35% 10
2023
Q2
$81.6M Sell
707,370
-18,114
-2% -$2.06M 1.45% 8
2023
Q1
$77.4M Sell
725,484
-4,114
-0.6% -$444K 1.47% 9
2022
Q4
$80.9M Sell
729,598
-13,140
-2% -$1.34M 1.59% 6
2022
Q3
$64M Buy
742,738
+47,247
+7% +$4.22M 1.3% 11
2022
Q2
$63.4M Buy
695,491
+12,325
+2% +$1.09M 1.45% 9
2022
Q1
$56.1M Buy
683,166
+8,510
+1% +$671K 1.1% 15
2021
Q4
$51.7M Buy
674,656
+1,293
+0.2% +$103K 0.98% 19
2021
Q3
$50.6M Buy
673,363
+111,043
+20% +$8.45M 1.05% 17
2021
Q2
$43.7M Sell
562,320
-1,418
-0.3% -$105K 1.05% 18
2021
Q1
$41.5M Buy
563,738
+19,560
+4% +$1.44M 1.07% 19
2020
Q4
$42.5M Sell
544,178
-90,502
-14% -$6.92M 1.27% 17
2020
Q3
$50.2M Buy
634,680
+2,802
+0.4% +$219K 1.82% 8
2020
Q2
$46.6M Buy
631,878
+1,742
+0.3% +$131K 1.85% 7
2020
Q1
$46.3M Buy
630,136
+43,904
+7% +$3.45M 2.18% 6
2019
Q4
$50.9M Sell
586,232
-7,176
-1% -$589K 2.04% 6
2019
Q3
$47.7M Sell
593,408
-3,313
-0.6% -$266K 2.05% 8
2019
Q2
$47.7M Buy
596,721
+11,523
+2% +$882K 2.07% 7
2019
Q1
$46.4M Sell
585,198
-1,030
-0.2% -$77K 2.1% 6
2018
Q4
$42.7M Buy
586,228
+160,407
+38% +$11.3M 2.19% 6
2018
Q3
$28.8M Buy
425,821
+8,830
+2% +$563K 1.41% 16
2018
Q2
$24.2M Buy
416,991
+16,114
+4% +$909K 1.26% 20
2018
Q1
$20.8M Sell
400,877
-8,947
-2% -$483K 1.13% 24
2017
Q4
$22M Buy
409,824
+8,657
+2% +$480K 1.18% 21
2017
Q3
$24.5M Sell
401,167
-14,635
-4% -$887K 1.41% 16
2017
Q2
$25.4M Buy
415,802
+14,318
+4% +$872K 1.52% 14
2017
Q1
$24.3M Sell
401,484
-2,817
-0.7% -$171K 1.5% 14
2016
Q4
$22.7M Buy
404,301
+3,877
+1% +$227K 1.47% 15
2016
Q3
$23.8M Buy
400,424
+1,376
+0.3% +$80.5K 1.59% 13
2016
Q2
$21.9M Buy
399,048
+6,144
+2% +$327K 1.51% 13
2016
Q1
$19.8M Buy
392,904
+11,128
+3% +$545K 1.39% 16
2015
Q4
$19.2M Sell
381,776
-5,441
-1% -$274K 1.35% 18
2015
Q3
$18.2M Buy
387,217
+30,704
+9% +$1.63M 1.37% 19
2015
Q2
$19.4M Buy
356,513
+6,829
+2% +$383K 1.36% 21
2015
Q1
$19.2M Sell
349,684
-1,823
-0.5% -$103K 1.33% 22
2014
Q4
$19M Buy
351,507
+5,852
+2% +$326K 1.34% 21
2014
Q3
$19.6M Buy
345,655
+7,678
+2% +$431K 1.46% 17
2014
Q2
$18.7M Buy
337,977
+3,303
+1% +$180K 1.4% 19
2014
Q1
$18.1M Sell
334,674
-2,878
-0.9% -$149K 1.43% 20
2013
Q4
$16.1M Sell
337,552
-1,520
-0.4% -$69.5K 1.3% 22
2013
Q3
$15.4M Sell
339,072
-5,873
-2% -$268K 1.35% 20
2013
Q2
$15.3M Buy
+344,945
New +$15.4M 1.4% 17

Other funds holding MRK

Peapack-Gladstone Financial Corp's MRK Position: Q1 2026 in Review

Peapack-Gladstone Financial Corp reduced its Merck (MRK) stake by 0.58% in Q1 2026, selling an estimated $377K and leaving 564,709 shares worth $67.9M. The position accounts for 0.87% of the portfolio, ranked #29.

Peapack-Gladstone Financial Corp first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $93.9M in Q1 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Peapack-Gladstone Financial Corp held 564,709 shares of Merck worth $67.9M as of Q1 2026.
  • Peapack-Gladstone Financial Corp sold 3,266 Merck shares in Q1 2026, an estimated $377K.
  • Merck made up 0.87% of Peapack-Gladstone Financial Corp's portfolio in Q1 2026, its #29 holding.
  • Peapack-Gladstone Financial Corp first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Peapack-Gladstone Financial Corp's Merck position peaked at $93.9M in Q1 2024.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Peapack-Gladstone Financial Corp's 13F filing for Q1 2026, filed 15 May 2026.